Association of Serum Uric Acid with Non-Valvular Atrial Fibrillation: A Retrospective Study in China

References

• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–847. doi:10.1161/CIRCULATIONAHA.113.005119
   PubMed Web of Science ®Google Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. doi:10.1177/1747493019897870
   PubMed Web of Science ®Google Scholar
• Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746–2751. doi:10.1093/eurheartj/eht280
   PubMed Web of Science ®Google Scholar
• Danese E, Montagnana M, Cervellin G, et al. Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence. Ann Med. 2014;46(6):364–371. doi:10.3109/07853890.2014.912835
   PubMed Web of Science ®Google Scholar
• Hyman DA, Siebert V, Jia X, et al. Risk assessment of stroke in patients with atrial fibrillation: current shortcomings and future directions. Cardiovasc Drug Ther. 2019;33(1):105–117. doi:10.1007/s10557-018-06849-7
   PubMed Web of Science ®Google Scholar
• Karakayali M, Artac I, Omar T, et al. Assessment of the efficacy of the electrocardiographic P-wave peak time in predicting atrial high rate episode in patients with cardiac implantable electronic devices. J Electrocardiol. 2023;80:40–44. doi:10.1016/j.jelectrocard.2023.05.001
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu Y, Ling Z, et al. Radiofrequency catheter ablation for paroxysmal atrial fibrillation: outcomes during a 3-year follow-up period. J Int Med Res. 2019;47(4):1636–1648. doi:10.1177/0300060519828522
   PubMed Web of Science ®Google Scholar
• Pinho-Gomes AC, Reilly S, Brandes RP, et al. Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. Antioxid Redox Sign. 2014;20(8):1268–1285. doi:10.1089/ars.2013.5542
   PubMed Web of Science ®Google Scholar
• Samman TA, Sandesara PB, Hayek SS, et al. Association between oxidative stress and atrial fibrillation. Heart Rhythm. 2017;14(12):1849–1855. doi:10.1016/j.hrthm.2017.07.028
   PubMed Web of Science ®Google Scholar
• Saito Y, Tanaka A, Node K, et al. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–57. doi:10.1016/j.jjcc.2020.12.013
   PubMed Web of Science ®Google Scholar
• Diallo A, Diallo MF, Carlos-Bolumbu M, et al. Uric acid-lowering effects of sodium-glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: a systematic review and meta-analysis. Diabetes Obes Metab. 2024;26(5):1980–1985. doi:10.1111/dom.15483
   PubMed Web of Science ®Google Scholar
• Cui K, Song Y, Yin D, et al. Uric acid levels, number of standard modifiable cardiovascular risk factors, and prognosis in patients with coronary artery disease: a large cohort study in Asia. J Am Heart Assoc. 2023;12(20):e030625. doi:10.1161/JAHA.123.030625
   PubMed Web of Science ®Google Scholar
• Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018;484:150–163. doi:10.1016/j.cca.2018.05.046
   PubMed Web of Science ®Google Scholar
• Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. Eur Heart j. 2006;27(10):1174–1181. doi:10.1093/eurheartj/ehi879
   PubMed Web of Science ®Google Scholar
• Kurajoh M, Fukumoto S, Yoshida S, et al. Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry. Sci Rep. 2021;11(1):7378. doi:10.1038/s41598-021-86962-0
   PubMed Web of Science ®Google Scholar
• Li N, Cui L, Shu R, et al. Distinct uric acid trajectories are associated with incident cardiac conduction block. Arthritis Res Ther. 2024;26(1):59. doi:10.1186/s13075-024-03288-8
   PubMed Web of Science ®Google Scholar
• Kwon CH, Lee SH, Lee JY, et al. Uric acid and risk of atrial fibrillation in the Korean general population. Circ J. 2018;82(11):2728–2735. doi:10.1253/circj.CJ-18-0748
   PubMed Web of Science ®Google Scholar
• Wang X, Hou Y, Wang X, et al. Relationship between serum uric acid levels and different types of atrial fibrillation: an updated meta-analysis. Nutr Metab Cardiovas. 2021;31(10):2756–2765. doi:10.1016/j.numecd.2021.05.034
   Web of Science ®Google Scholar
• Redon P, Maloberti A, Facchetti R, et al. Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study. J Hypertens. 2019;37(2):380–388. doi:10.1097/HJH.0000000000001908
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48(4):854–906. doi:10.1016/j.jacc.2006.07.009
   PubMed Web of Science ®Google Scholar
• Borges RL, Ribeiro AB, Zanella MT, et al. Uric acid as a factor in the metabolic syndrome. Curr Hypertens Rep. 2010;12(2):113–119. doi:10.1007/s11906-010-0098-2
   PubMed Web of Science ®Google Scholar
• Watanabe E. Uric acid and atrial fibrillation - cause or other association? Circ J. 2012;76(3):584–585. doi:10.1253/circj.CJ-12-0057
   PubMed Web of Science ®Google Scholar
• Borghi C, Domienik-Karlowicz J, Tykarski A, et al. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update. Cardiol J. 2021;28(1):1–14. doi:10.5603/CJ.a2021.0001
   PubMed Web of Science ®Google Scholar
• Yu W, Cheng JD. Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective. Front Pharmacol. 2020;11:582680. doi:10.3389/fphar.2020.582680
   PubMed Web of Science ®Google Scholar
• Karabag Y, Rencuzogullari I, Cagdas M, et al. Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease. Int J Cardiovas Imag. 2019;35(1):1–7. doi:10.1007/s10554-018-1446-6
   PubMed Web of Science ®Google Scholar
• Zhang W, Iso H, Murakami Y, et al. Serum uric acid and mortality form cardiovascular disease: EPOCH-Japan Study. J Atheroscler Thromb. 2016;23(6):692–703. doi:10.5551/jat.31591
   PubMed Web of Science ®Google Scholar
• Kleber ME, Delgado G, Grammer TB, et al. Uric acid and cardiovascular events: a Mendelian randomization study. J Am Soc Nephrol. 2015;26(11):2831–2838. doi:10.1681/ASN.2014070660
   PubMed Web of Science ®Google Scholar
• Korantzopoulos P, Kolettis TM, Galaris D, et al. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007;115(2):135–143. doi:10.1016/j.ijcard.2006.04.026
   PubMed Web of Science ®Google Scholar
• Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–243. doi:10.1038/nrcardio.2015.2
   PubMed Web of Science ®Google Scholar
• Deng Y, Liu F, Yang X, et al. The key role of uric acid in oxidative stress, inflammation, fibrosis, apoptosis, and immunity in the pathogenesis of atrial fibrillation. Front Cardiovasc Med. 2021;8:641136. doi:10.3389/fcvm.2021.641136
   PubMed Web of Science ®Google Scholar
• Tapoi L, Salaru DL, Sascau R, et al. Uric acid-an emergent risk marker for thrombosis? J Clin Med. 2021;10(10):2062. doi:10.3390/jcm10102062
   PubMed Web of Science ®Google Scholar
• Maharani N, Kuwabara M, Hisatome I. Hyperuricemia and atrial fibrillation. Int Heart J. 2016;57(4):395–399. doi:10.1536/ihj.16-192
   PubMed Web of Science ®Google Scholar
• Sun X, Jiao H, Zhao J, et al. Unexpected effect of urate on hydrogen peroxide-induced oxidative damage in embryonic chicken cardiac cells. Free Radical Res. 2017;51(7–8):693–707. doi:10.1080/10715762.2017.1362106
   PubMed Web of Science ®Google Scholar
• Doehner W, Landmesser U. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Semin Nephrol. 2011;31(5):433–440. doi:10.1016/j.semnephrol.2011.08.007
   PubMed Web of Science ®Google Scholar
• Lyngdoh T, Marques-Vidal P, Paccaud F, et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One. 2011;6(5):e19901. doi:10.1371/journal.pone.0019901
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhang XL, Fu C, et al. Soluble uric acid increases NALP3 inflammasome and interleukin-1beta expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway. Int J Mol Med. 2015;35(5):1347–1354. doi:10.3892/ijmm.2015.2148
   PubMed Web of Science ®Google Scholar
• Taufiq F, Maharani N, Li P, et al. Uric acid-induced enhancements of Kv1.5 protein expression and channel activity via the Akt-HSF1-Hsp70 pathway in HL-1 atrial myocytes. CIRC J. 2019;83(4):718–726. doi:10.1253/circj.CJ-18-1088
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Kokubo Y, Higashiyama A, et al. Uric acid and incident atrial fibrillation of 14 years population-based cohort study: the Suita Study. J Arrythm. 2021;37(5):1215–1219. doi:10.1002/joa3.12612
   PubMed Web of Science ®Google Scholar
• Nyrnes A, Toft I, Njolstad I, et al. Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--The Tromso Study. Europace. 2014;16(3):320–326. doi:10.1093/europace/eut260
   PubMed Web of Science ®Google Scholar
• Suzuki S, Sagara K, Otsuka T, et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J. 2012;76(3):607–611. doi:10.1253/circj.CJ-11-1111
   PubMed Web of Science ®Google Scholar
• Sun GZ, Guo L, Wang J, et al. Association between hyperuricemia and atrial fibrillation in rural China: a cross-sectional study. BMC Cardiovasc Disor. 2015;15(1):98. doi:10.1186/s12872-015-0089-y
   PubMedGoogle Scholar
• Rahimi-Sakak F, Maroofi M, Rahmani J, et al. Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants. BMC Cardiovasc Disor. 2019;19(1):218. doi:10.1186/s12872-019-1215-z
   PubMed Web of Science ®Google Scholar
• Li Q, Li X, Wang J, et al. Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ OPEN. 2019;9(8):e026677. doi:10.1136/bmjopen-2018-026677
   PubMed Web of Science ®Google Scholar
• Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12. doi:10.1016/j.ejim.2018.04.014
   PubMed Web of Science ®Google Scholar
• Sheinenzon A, Shehadeh M, Michelis R, et al. Serum albumin levels and inflammation. Int J Biol Macromol. 2021;184:857–862. doi:10.1016/j.ijbiomac.2021.06.140
   PubMed Web of Science ®Google Scholar
• Liao LZ, Zhang SZ, Li WD, et al. Serum albumin and atrial fibrillation: insights from epidemiological and Mendelian randomization studies. Eur J Epidemiol. 2020;35(2):113–122. doi:10.1007/s10654-019-00583-6
   PubMed Web of Science ®Google Scholar
• Pal GK, Shyma P, Habeebullah S, et al. Association of albumin-globulin ratio with sympathovagal imbalance in pregnancy-induced hypertension. Indian J Physiol Pharmacol. 2011;55(2):128–138.
   PubMedGoogle Scholar
• Du R, Winarsih I, Ho B, et al. Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobin. Am J Clin Exp Immuno. 2012;1(1):33–48.
   PubMedGoogle Scholar
• Cinar T, Tanik VO, Gurkan K. Comparison of apolipoprotein-A1 levels between paroxysmal atrial fibrillation patients and healthy subjects. J Cardiovasc Thorac. 2020;12(2):140–144. doi:10.34172/jcvtr.2020.23
   PubMed Web of Science ®Google Scholar
• Tang RB, Dong JZ, Yan XL, et al. Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol. 2014;30(11):1415–1421. doi:10.1016/j.cjca.2014.06.009
   PubMed Web of Science ®Google Scholar
• De Lucchi L, Nardin C, Sponchiado A, et al. Serum uric acid levels and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2021;19(1):194–201. doi:10.1111/jth.15139
   PubMed Web of Science ®Google Scholar